Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mental Disorders | 13 | 2024 | 114 | 3.650 |
Why?
|
| Neuropsychological Tests | 38 | 2020 | 249 | 3.200 |
Why?
|
| Cognition Disorders | 19 | 2017 | 186 | 1.950 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 6 | 2023 | 31 | 1.500 |
Why?
|
| Geriatric Assessment | 16 | 2014 | 91 | 1.280 |
Why?
|
| Adolescent | 36 | 2024 | 3193 | 1.230 |
Why?
|
| Child Abuse | 3 | 2024 | 92 | 1.120 |
Why?
|
| Psychotic Disorders | 5 | 2022 | 23 | 1.070 |
Why?
|
| Male | 66 | 2024 | 13921 | 1.010 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2024 | 19 | 1.010 |
Why?
|
| Female | 71 | 2024 | 15624 | 1.000 |
Why?
|
| Young Adult | 24 | 2024 | 2833 | 0.990 |
Why?
|
| Age Factors | 17 | 2019 | 737 | 0.910 |
Why?
|
| Exercise | 3 | 2018 | 497 | 0.900 |
Why?
|
| Health Risk Behaviors | 1 | 2024 | 7 | 0.880 |
Why?
|
| Gender Identity | 1 | 2024 | 25 | 0.870 |
Why?
|
| Humans | 81 | 2024 | 28851 | 0.860 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2022 | 100 | 0.860 |
Why?
|
| Parkinson Disease | 4 | 2016 | 47 | 0.800 |
Why?
|
| Delusions | 4 | 2017 | 4 | 0.780 |
Why?
|
| Neuropsychology | 2 | 2020 | 10 | 0.770 |
Why?
|
| Child | 18 | 2024 | 2287 | 0.740 |
Why?
|
| Longitudinal Studies | 18 | 2021 | 429 | 0.720 |
Why?
|
| Educational Status | 8 | 2016 | 112 | 0.710 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 118 | 0.700 |
Why?
|
| Psychometrics | 8 | 2016 | 122 | 0.700 |
Why?
|
| Adult | 31 | 2024 | 8024 | 0.690 |
Why?
|
| Sodium Benzoate | 1 | 2020 | 2 | 0.680 |
Why?
|
| Australia | 8 | 2024 | 40 | 0.670 |
Why?
|
| Subthalamic Nucleus | 2 | 2012 | 3 | 0.670 |
Why?
|
| Deep Brain Stimulation | 2 | 2012 | 11 | 0.660 |
Why?
|
| Child Language | 2 | 2017 | 3 | 0.650 |
Why?
|
| Language Development Disorders | 2 | 2017 | 4 | 0.650 |
Why?
|
| Cognition | 7 | 2017 | 331 | 0.640 |
Why?
|
| Conduct Disorder | 2 | 2017 | 2 | 0.640 |
Why?
|
| Mental Health | 2 | 2021 | 111 | 0.640 |
Why?
|
| Antifungal Agents | 1 | 2020 | 69 | 0.630 |
Why?
|
| Substance-Related Disorders | 7 | 2023 | 190 | 0.620 |
Why?
|
| Health Status | 4 | 2015 | 149 | 0.620 |
Why?
|
| Aged | 42 | 2019 | 5598 | 0.620 |
Why?
|
| Disease Progression | 2 | 2018 | 477 | 0.610 |
Why?
|
| Hallucinations | 2 | 2017 | 5 | 0.600 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2023 | 11 | 0.570 |
Why?
|
| Cognitive Dysfunction | 3 | 2017 | 271 | 0.550 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2017 | 1 | 0.540 |
Why?
|
| Aged, 80 and over | 29 | 2019 | 2065 | 0.530 |
Why?
|
| Vocabulary | 2 | 2016 | 7 | 0.530 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 68 | 0.510 |
Why?
|
| Employment | 1 | 2016 | 49 | 0.500 |
Why?
|
| Middle Aged | 27 | 2024 | 7414 | 0.480 |
Why?
|
| Queensland | 5 | 2018 | 7 | 0.480 |
Why?
|
| Psychomotor Performance | 4 | 2011 | 72 | 0.480 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2015 | 2 | 0.470 |
Why?
|
| Task Performance and Analysis | 2 | 2015 | 43 | 0.460 |
Why?
|
| Global Burden of Disease | 3 | 2020 | 7 | 0.450 |
Why?
|
| Marijuana Smoking | 1 | 2015 | 35 | 0.450 |
Why?
|
| Mortality | 1 | 2015 | 46 | 0.440 |
Why?
|
| Cohort Studies | 9 | 2023 | 897 | 0.420 |
Why?
|
| Follow-Up Studies | 8 | 2017 | 1032 | 0.420 |
Why?
|
| Tobacco Use | 1 | 2015 | 103 | 0.410 |
Why?
|
| Comorbidity | 6 | 2023 | 261 | 0.400 |
Why?
|
| Wounds and Injuries | 4 | 2019 | 191 | 0.400 |
Why?
|
| Child, Preschool | 9 | 2021 | 1173 | 0.380 |
Why?
|
| Reproducibility of Results | 23 | 2015 | 787 | 0.370 |
Why?
|
| Global Health | 4 | 2019 | 54 | 0.370 |
Why?
|
| Residence Characteristics | 10 | 2013 | 105 | 0.370 |
Why?
|
| Intelligence | 6 | 2008 | 27 | 0.350 |
Why?
|
| Adolescent Health | 3 | 2021 | 7 | 0.330 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2020 | 8 | 0.320 |
Why?
|
| Case-Control Studies | 5 | 2020 | 739 | 0.310 |
Why?
|
| Pre-Eclampsia | 2 | 2020 | 49 | 0.310 |
Why?
|
| Risk Factors | 8 | 2021 | 2126 | 0.310 |
Why?
|
| Self Report | 5 | 2016 | 121 | 0.290 |
Why?
|
| Health Surveys | 4 | 2024 | 85 | 0.290 |
Why?
|
| Child Health | 2 | 2019 | 17 | 0.280 |
Why?
|
| Registries | 4 | 2019 | 396 | 0.280 |
Why?
|
| Prevalence | 4 | 2024 | 518 | 0.280 |
Why?
|
| Quality-Adjusted Life Years | 4 | 2020 | 18 | 0.280 |
Why?
|
| Depression | 5 | 2021 | 225 | 0.260 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2019 | 136 | 0.260 |
Why?
|
| Child Behavior Disorders | 3 | 2020 | 25 | 0.260 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 995 | 0.250 |
Why?
|
| Surveys and Questionnaires | 3 | 2015 | 997 | 0.250 |
Why?
|
| Denmark | 4 | 2020 | 27 | 0.250 |
Why?
|
| Treatment Outcome | 3 | 2020 | 2426 | 0.240 |
Why?
|
| Memory Disorders | 3 | 2015 | 50 | 0.230 |
Why?
|
| Infant | 6 | 2021 | 1025 | 0.230 |
Why?
|
| Depressive Disorder, Major | 2 | 2017 | 127 | 0.220 |
Why?
|
| Indonesia | 1 | 2024 | 2 | 0.220 |
Why?
|
| Foster Home Care | 1 | 2024 | 6 | 0.220 |
Why?
|
| Kenya | 1 | 2024 | 34 | 0.210 |
Why?
|
| Intelligence Tests | 4 | 2015 | 25 | 0.210 |
Why?
|
| Vietnam | 1 | 2024 | 46 | 0.210 |
Why?
|
| Prospective Studies | 4 | 2020 | 1280 | 0.210 |
Why?
|
| Mortality, Premature | 2 | 2020 | 3 | 0.200 |
Why?
|
| Pregnancy Complications | 2 | 2021 | 112 | 0.190 |
Why?
|
| Semantics | 1 | 2002 | 11 | 0.190 |
Why?
|
| Brain Diseases | 4 | 2006 | 36 | 0.190 |
Why?
|
| Reference Values | 7 | 2011 | 200 | 0.190 |
Why?
|
| Alzheimer Disease | 3 | 2013 | 225 | 0.180 |
Why?
|
| Time Factors | 6 | 2019 | 1613 | 0.180 |
Why?
|
| United Nations | 1 | 2021 | 2 | 0.180 |
Why?
|
| Cannabis | 1 | 2022 | 46 | 0.180 |
Why?
|
| Depression, Postpartum | 1 | 2021 | 15 | 0.180 |
Why?
|
| Aggression | 1 | 2021 | 26 | 0.180 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 39 | 0.170 |
Why?
|
| Visual Perception | 4 | 2013 | 45 | 0.170 |
Why?
|
| Placebos | 1 | 2020 | 48 | 0.170 |
Why?
|
| Mood Disorders | 2 | 2019 | 25 | 0.170 |
Why?
|
| Logistic Models | 3 | 2017 | 410 | 0.170 |
Why?
|
| Anxiety Disorders | 2 | 2019 | 65 | 0.170 |
Why?
|
| Life Expectancy | 1 | 2020 | 23 | 0.160 |
Why?
|
| Sensitivity and Specificity | 8 | 2017 | 524 | 0.160 |
Why?
|
| Schizophrenia | 1 | 2020 | 51 | 0.160 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 209 | 0.160 |
Why?
|
| Alcoholism | 2 | 2020 | 121 | 0.160 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 52 | 0.150 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2015 | 216 | 0.150 |
Why?
|
| Morbidity | 1 | 2019 | 60 | 0.150 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2019 | 10 | 0.150 |
Why?
|
| Wechsler Scales | 3 | 2003 | 12 | 0.150 |
Why?
|
| Anxiety | 2 | 2021 | 158 | 0.150 |
Why?
|
| Aging | 5 | 2007 | 1016 | 0.140 |
Why?
|
| Medicare | 1 | 2019 | 126 | 0.140 |
Why?
|
| Pregnancy | 5 | 2021 | 1254 | 0.140 |
Why?
|
| Malingering | 2 | 2011 | 10 | 0.140 |
Why?
|
| Universities | 2 | 2016 | 124 | 0.140 |
Why?
|
| Transferrin | 1 | 2017 | 10 | 0.130 |
Why?
|
| Ferritins | 1 | 2017 | 27 | 0.130 |
Why?
|
| Executive Function | 1 | 2017 | 27 | 0.130 |
Why?
|
| Preliminary Data | 1 | 2016 | 4 | 0.130 |
Why?
|
| Memory, Short-Term | 3 | 2014 | 64 | 0.130 |
Why?
|
| Child Behavior | 1 | 2017 | 30 | 0.130 |
Why?
|
| Predictive Value of Tests | 10 | 2008 | 485 | 0.130 |
Why?
|
| Risk | 1 | 2017 | 138 | 0.130 |
Why?
|
| United States | 2 | 2022 | 2222 | 0.130 |
Why?
|
| Quality of Life | 1 | 2020 | 521 | 0.120 |
Why?
|
| Algorithms | 5 | 2006 | 431 | 0.120 |
Why?
|
| Sex Factors | 5 | 2019 | 467 | 0.120 |
Why?
|
| Attention | 6 | 2013 | 91 | 0.120 |
Why?
|
| Demography | 9 | 2006 | 93 | 0.120 |
Why?
|
| Food Hypersensitivity | 1 | 2016 | 4 | 0.120 |
Why?
|
| Iron | 1 | 2017 | 117 | 0.120 |
Why?
|
| Verbal Learning | 2 | 2006 | 14 | 0.120 |
Why?
|
| Parents | 1 | 2017 | 133 | 0.120 |
Why?
|
| United Kingdom | 3 | 2020 | 78 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2016 | 268 | 0.110 |
Why?
|
| Cholinergic Antagonists | 1 | 2014 | 4 | 0.110 |
Why?
|
| Asthma | 1 | 2016 | 60 | 0.110 |
Why?
|
| Brain Neoplasms | 2 | 2008 | 312 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 676 | 0.110 |
Why?
|
| Independent Living | 1 | 2014 | 14 | 0.110 |
Why?
|
| Mothers | 3 | 2021 | 124 | 0.100 |
Why?
|
| Checklist | 1 | 2013 | 22 | 0.100 |
Why?
|
| Epilepsy | 1 | 2013 | 37 | 0.100 |
Why?
|
| Students | 1 | 2015 | 199 | 0.100 |
Why?
|
| Socioeconomic Factors | 3 | 2019 | 260 | 0.090 |
Why?
|
| Antiparkinson Agents | 1 | 2012 | 3 | 0.090 |
Why?
|
| Age Distribution | 4 | 2019 | 73 | 0.090 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 5 | 0.090 |
Why?
|
| Verbal Behavior | 2 | 2008 | 9 | 0.090 |
Why?
|
| Memory | 3 | 2013 | 76 | 0.090 |
Why?
|
| Regression Analysis | 6 | 2008 | 211 | 0.080 |
Why?
|
| Suicide | 2 | 2020 | 11 | 0.080 |
Why?
|
| Analysis of Variance | 4 | 2017 | 391 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2010 | 173 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 2 | 2006 | 43 | 0.080 |
Why?
|
| Language | 5 | 2013 | 65 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 377 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 465 | 0.070 |
Why?
|
| Cause of Death | 2 | 2019 | 73 | 0.070 |
Why?
|
| Mental Processes | 2 | 2005 | 16 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2011 | 233 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 237 | 0.070 |
Why?
|
| Chi-Square Distribution | 3 | 2017 | 145 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2019 | 916 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2007 | 20 | 0.070 |
Why?
|
| Dementia | 2 | 2010 | 97 | 0.060 |
Why?
|
| Mental Recall | 1 | 2007 | 51 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2019 | 78 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 302 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2021 | 2635 | 0.060 |
Why?
|
| Problem Solving | 1 | 2005 | 28 | 0.060 |
Why?
|
| Speech Perception | 1 | 2005 | 29 | 0.060 |
Why?
|
| Disease | 1 | 2004 | 15 | 0.060 |
Why?
|
| Pattern Recognition, Visual | 1 | 2005 | 37 | 0.060 |
Why?
|
| Psychological Theory | 1 | 2004 | 30 | 0.050 |
Why?
|
| Neoplasms | 1 | 2013 | 874 | 0.050 |
Why?
|
| Huntington Disease | 1 | 2003 | 9 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2014 | 126 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 71 | 0.050 |
Why?
|
| Community Health Planning | 2 | 2013 | 14 | 0.050 |
Why?
|
| Finland | 1 | 2022 | 4 | 0.050 |
Why?
|
| Data Accuracy | 1 | 2022 | 11 | 0.050 |
Why?
|
| Probability | 1 | 2022 | 78 | 0.050 |
Why?
|
| ADAMTS13 Protein | 2 | 2015 | 126 | 0.050 |
Why?
|
| ADAM Proteins | 2 | 2015 | 103 | 0.050 |
Why?
|
| Forecasting | 1 | 2022 | 76 | 0.050 |
Why?
|
| African Americans | 1 | 2003 | 352 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2011 | 29 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 115 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 95 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 199 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 17 | 0.040 |
Why?
|
| Child Mortality | 1 | 2017 | 4 | 0.030 |
Why?
|
| Western Australia | 1 | 2017 | 2 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 2 | 2008 | 46 | 0.030 |
Why?
|
| Maternal Behavior | 1 | 2017 | 9 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 108 | 0.030 |
Why?
|
| Fathers | 1 | 2017 | 15 | 0.030 |
Why?
|
| Oklahoma | 2 | 2014 | 1052 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 40 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 303 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 144 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 237 | 0.030 |
Why?
|
| Convalescence | 1 | 2015 | 6 | 0.030 |
Why?
|
| Cognitive Aging | 1 | 2014 | 22 | 0.030 |
Why?
|
| Plasma Exchange | 1 | 2015 | 104 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 811 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 202 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 417 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2014 | 161 | 0.020 |
Why?
|
| Smoking | 1 | 2017 | 477 | 0.020 |
Why?
|
| Family | 1 | 2013 | 99 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 379 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 572 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2008 | 21 | 0.020 |
Why?
|
| Survivors | 1 | 2007 | 40 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 106 | 0.020 |
Why?
|
| Reference Standards | 1 | 2006 | 57 | 0.020 |
Why?
|
| Bias | 1 | 2006 | 42 | 0.020 |
Why?
|
| Repression, Psychology | 1 | 2005 | 5 | 0.010 |
Why?
|
| Paired-Associate Learning | 1 | 2005 | 6 | 0.010 |
Why?
|
| Discrimination Learning | 1 | 2005 | 8 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2005 | 79 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 2003 | 20 | 0.010 |
Why?
|
| Mental Status Schedule | 1 | 2003 | 9 | 0.010 |
Why?
|
| Reading | 1 | 2003 | 19 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 79 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2007 | 634 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 151 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 769 | 0.010 |
Why?
|
| Motivation | 1 | 2003 | 216 | 0.010 |
Why?
|